- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| Fr | SciBase: Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue | 190 | PR Newswire | STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April... ► Artikel lesen | |
| 27.01. | SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 261 | PR Newswire | STOCKHOLM, Jan. 27, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on... ► Artikel lesen | |
| 27.01. | Scibase Holding AB: SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 113 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on 29 December 2025 (the "Rights Issue"). The Rights Issue... ► Artikel lesen | |
| 26.01. | SciBase: Change of date for publication of the year-end report for the financial year 2025 | 223 | PR Newswire | STOCKHOLM, Jan. 26, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has resolved to postpone the publication of the year-end report for... ► Artikel lesen | |
| 22.01. | Increased commitment in SciBase rights issue | 189 | PR Newswire | STOCKHOLM, Jan. 22, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announces it has been informed... ► Artikel lesen | |
| 09.01. | SciBase publishes information document regarding rights issue | 326 | PR Newswire | STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") publishes information documents in connection with the rights issue... ► Artikel lesen | |
| 09.01. | SciBase announces outcome of the offer to repurchase outstanding warrants of series TO 2 | 253 | PR Newswire | STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the outcome of the repurchase offer for all warrants of series TO 2 resolved... ► Artikel lesen | |
| 06.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.01.2026 | 402 | Xetra Newsboard | Das Instrument NW1 SE0017131865 WINDON ENERGY GROUP AB EQUITY wird cum Kapitalmassnahme gehandelt am 06.01.2026 und ex Kapitalmassnahme am 07.01.2026 The instrument NW1 SE0017131865 WINDON ENERGY GROUP... ► Artikel lesen | |
| 29.12.25 | The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million | 702 | PR Newswire | STOCKHOLM, Dec. 29, 2025 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, based on the authorization granted by the Annual General... ► Artikel lesen | |
| 11.12.25 | SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent | 302 | PR Newswire | STOCKHOLM, Dec. 11, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that it has been granted... ► Artikel lesen | |
| 05.12.25 | SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 | 427 | PR Newswire | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") publishes an information document in connection with the offer to repurchase all outstanding... ► Artikel lesen | |
| 05.12.25 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 255 | PR Newswire | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 05.12.25 | Scibase Holding AB: Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 255 | GlobeNewswire (Europe) | Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposal presented in the notice... ► Artikel lesen | |
| 21.11.25 | SCIBASE: The exercise price for warrants of series TO 3 has been determined | 2 | Cision News | ||
| 07.11.25 | SciBase: Interim report | 271 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ --
January 1 - September 30, 2025
The third quarter in figures
Net sales were TSEK 10,339 (8,408), +23%, cleared... ► Artikel lesen | |
| 07.11.25 | The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million | 322 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- The Board of Directors in SciBase Holding AB (publ) ("SciBase" or the "Company") has today resolved to make a repurchase offer for all 498,534... ► Artikel lesen | |
| 07.11.25 | SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million | 376 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that SciBase... ► Artikel lesen | |
| 22.10.25 | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026 | 250 | PR Newswire | STOCKHOLM, Oct. 22, 2025 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2026:
Anders... ► Artikel lesen | |
| 26.09.25 | SciBase: Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis | 349 | PR Newswire | STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen | |
| 23.09.25 | SciBase receives initial order for clinical study from Castle Biosciences | 353 | PR Newswire | STOCKHOLM, Sept. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 73,07 | +0,63 % | This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday | ||
| SERNOVA BIOTHERAPEUTICS | 0,086 | -7,53 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 63,80 | -1,24 % | ROUNDUP: Boston Scientific Guides Q1, FY26 In Line With Estimates | WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales... ► Artikel lesen | |
| PAUL HARTMANN | 222,00 | -0,89 % | Vorläufiges Jahresergebnis 2025: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - Die HARTMANN GRUPPE hat im Geschäftsjahr 2025 ein vorläufiges organisches Umsatzwachstum von 2,2 % erzielt.Das vorläufige bereinigte EBITDA liegt mit 277 Mio. EUR um rund 15 Mio.... ► Artikel lesen | |
| SYSMEX | 8,150 | 0,00 % | Fujirebio und Sysmex beginnen Vertriebskooperation für Demenz-Tests | Fujirebio Holdings, Inc. (Zentrale: Minato-ku, Tokio; President CEO: Goki Ishikawa; "Fujirebio"), eine konsolidierte Tochtergesellschaft der H.U. Group Holdings, Inc. (Zentrale: Minato-ku, Tokio;... ► Artikel lesen | |
| ADDLIFE | 14,370 | -0,83 % | AddLife AB: Year-end report January 1 - December 31, 2025 | Continued positive margin development, strong profit and cash flow"The EBITA margin continues to develop positively and profits are growing. The strong cash flow means that our ambition to reduce the... ► Artikel lesen | |
| EMBECTA | 9,150 | -0,54 % | Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results | PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ENOVIS | 19,000 | -0,52 % | Enovis Corporation: Enovis Appoints Oliver Engert as Chief Administrative Officer | Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative... ► Artikel lesen | |
| PULMONX | 1,310 | +2,34 % | Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates | WASHINGTON (dpa-AFX) - Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity.Pulmonx... ► Artikel lesen | |
| KOOTH | 1,520 | 0,00 % | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | ||
| PEIJIA MEDICAL | 0,685 | 0,00 % | PEIJIA-B (09996): VOLUNTARY ANNOUNCEMENT - UNAUDITED OPERATING STATISTICS FOR THE YEAR ENDED DECEMBER 31, 2025 | ||
| SI-BONE | 12,900 | -0,77 % | SI-BONE To Report Q4 And FY2025 Results This Month; What Does Preliminary Results Indicate? | ||
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| LIFECARE ASA | 0,022 | -43,01 % | Lifecare ASA: Lifecare submits updated documentation to NoMA: regulatory review resumes in first-in-human study application | ||
| BACTIGUARD | 1,395 | +12,05 % | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2025 | A year of strategic execution concluded with a strong Q4
Fourth quarter 2025 (October - December)
Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to... ► Artikel lesen |
SCIBASE HOLDING AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,75 % bei einem Aktienkurs von 0,026 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.